Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.

Dabbous FM, Dolecek TA, Berbaum ML, Friedewald SM, Summerfelt WT, Hoskins K, Rauscher GH.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):397-403. doi: 10.1158/1055-9965.EPI-16-0524. Epub 2017 Feb 9.

PMID:
28183826
2.

Symptom distress associated with biopsy in women with suspect breast lesions.

Kamath J, Cruess DG, Claffey K, Wilson L, Phoenix N, Tannenbaum S.

ISRN Oncol. 2012;2012:898327. doi: 10.5402/2012/898327. Epub 2012 Jul 8.

3.

A prospective assessment of racial/ethnic differences in future mammography behavior among women who had early mammography.

Kapp JM, Walker R, Haneuse S, Yankaskas BC.

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):600-8. doi: 10.1158/1055-9965.EPI-10-1070. Epub 2011 Jan 17.

4.

Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.

Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, Pisano ED, Evans WP 3rd, Mahoney MC, Hovanessian Larsen L, Gabrielli GJ, Mendelson EB.

Radiology. 2010 Jan;254(1):79-87. doi: 10.1148/radiol.2541090953.

5.

Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.

Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Extermann M, Fox S, Orosz G, Silliman R, Cullen J, Balducci L; Breast Cancer in Older Women Research Consortium.

J Gen Intern Med. 2005 Jun;20(6):487-96.

6.

International variation in screening mammography interpretations in community-based programs.

Elmore JG, Nakano CY, Koepsell TD, Desnick LM, D'Orsi CJ, Ransohoff DF.

J Natl Cancer Inst. 2003 Sep 17;95(18):1384-93.

7.

Clinical practice. Mammographic screening for breast cancer.

Fletcher SW, Elmore JG.

N Engl J Med. 2003 Apr 24;348(17):1672-80. Review. No abstract available.

Supplemental Content

Support Center